- Company profile - - Activities - - Marketing - - Company profile - - Activities - - Marketing - - Company profile - - Contract manufacturing - - Marketing - - Company profile - - Contract manufacturing - - Marketing - - Products - - Contract manufacturing - - Marketing - - Products - - Contract manufacturing - - Manufacturing facilities - - Products - - Contract manufacturing - - Manufacturing facilities - - Products - - R e D activities - - Manufacturing facilities - - Products - - R e D activities - - Manufacturing facilities - - Contacts - - R e D activities - - Manufacturing facilities - - Contacts - - R e D activities - - Contacts -
- Home Page -

R&D activities

In addition to pharmaceutical formulations, CT laboratories' R&D division, is focused on the development of original chemical entities targeted to the treatment of alcohol addiction/abuse and depression/anxiety disorders.

A) CHEMICAL SYNTHESIS

  • Laboratory scale synthesis.

B) CHEMICAL DEVELOPMENT

  • Study of chemical structure (NMR, IR, NIR, Elemental Analysis),
  • Analytical development with validation studies.

C) PHARMACOLOGICAL ACTIVITIES

  • Preliminary pharmacological screening by means of behavioural tests to define neuropharmacological profile,
  • Evaluation of selected molecules by specific animal models (ethanol intake in rats, withdrawal syndrome in rats and other species),
  • Tests of receptorial binding (outsourcing),
  • Pharmacokinetic studies in small animals (rats and rabbits),
  • Initial toxicological data (LD50).


© Copyright 2001 - CT Laboratories - All Rights Reserved